TOLERANCE TO BACTERIAL PYROGENS .1. FACTORS INFLUENCING ITS DEVELOPMENT

[1] Banks H.M., 1934, AM J CLIN PATHOL, V4, P260

[2] BECK LV, 1946, CANCER RES, V6, P410

[3] BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248

[4] Chapman Cicily J., 1942, QUART JOUR PHARM AND PHARMACOL, V15, P361

[5] Ellingson HV, 1942, J IMMUNOL, V43, P65

[6] Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa - Clinical, hematological, chemical and serological studies [J]. JOURNAL OF CLINICAL INVESTIGATION, 1942, 21 (05) : 589 - 599

[7] Hartwell JL, 1943, J NATL CANCER I, V4, P107

[8] Heyman A., 1945, VEN DIS INFORM, V26, P51

[9] Mc Closky W, 1943, J AM PHARM ASS, V32, P69

[10] Morgan HR, 1943, AM J PATHOL, V19, P135

[1] Banks H.M., 1934, AM J CLIN PATHOL, V4, P260

[2] BECK LV, 1946, CANCER RES, V6, P410

[3] BEESON PB, 1946, P SOC EXP BIOL MED, V61, P248

[4] Chapman Cicily J., 1942, QUART JOUR PHARM AND PHARMACOL, V15, P361

[5] Ellingson HV, 1942, J IMMUNOL, V43, P65

[6] Effects produced by the intravenous injection in man of a toxic antigenic material derived from Eberthella typhosa - Clinical, hematological, chemical and serological studies [J]. JOURNAL OF CLINICAL INVESTIGATION, 1942, 21 (05) : 589 - 599

[7] Hartwell JL, 1943, J NATL CANCER I, V4, P107

[8] Heyman A., 1945, VEN DIS INFORM, V26, P51

[9] Mc Closky W, 1943, J AM PHARM ASS, V32, P69

[10] Morgan HR, 1943, AM J PATHOL, V19, P135